Novel agents for KRAS-mutant NSCLC

被引：0
|
作者：
Janne, Pasi A. [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.05.477
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY20-1
引用
收藏
页码：S444 / S444
页数：1
相关论文
共 50 条
  • [41] Personalizing KRAS-Mutant Allele-Specific Therapies
    Falcomata, Chiara
    Schneider, Guenter
    Saur, Dieter
    CANCER DISCOVERY, 2020, 10 (01) : 23 - 25
  • [42] A combinatorial strategy for treating KRAS-mutant lung cancer
    Eusebio Manchado
    Susann Weissmueller
    John P. Morris
    Chi-Chao Chen
    Ramona Wullenkord
    Amaia Lujambio
    Elisa de Stanchina
    John T. Poirier
    Justin F. Gainor
    Ryan B. Corcoran
    Jeffrey A. Engelman
    Charles M. Rudin
    Neal Rosen
    Scott W. Lowe
    Nature, 2016, 534 : 647 - 651
  • [43] A combinatorial strategy for treating KRAS-mutant lung cancer
    Manchado, Eusebio
    Weissmueller, Susann
    Morris, John P.
    Chen, Chi-Chao
    Wullenkord, Ramona
    Lujambio, Amaia
    de Stanchina, Elisa
    Poirier, John T.
    Gainor, Justin F.
    Corcoran, Ryan B.
    Engelman, Jeffrey A.
    Rudin, Charles M.
    Rosen, Neal
    Lowe, Scott W.
    NATURE, 2016, 534 (7609) : 647 - +
  • [44] Hope for targeted treatment of KRAS-mutant lung cancer
    Crisp, Alisa
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (02) : 121 - 121
  • [45] Targeting metabolic peculiarities: a potentially novel therapeutic approach for KRAS-mutant lung cancer?
    Abdel-Rahman, Omar
    JOURNAL OF THORACIC DISEASE, 2016, 8 (08) : E794 - E795
  • [46] Suppressing Nucleotide Exchange to Inhibit KRAS-Mutant Tumors
    Zhao, Yulei
    Xue, Jenny Y.
    Lito, Piro
    CANCER DISCOVERY, 2021, 11 (01) : 17 - 19
  • [47] Post-COVID-19 Tumor Microenvironment Features and AI-Based Evaluation in KRAS-Mutant NSCLC
    Huang, Z.
    Li, L.
    Wang, S.
    Peng, Z.
    Jia, Y.
    Zhang, J.
    He, Q.
    Zeng, S.
    Yang, B.
    He, Y.
    Guan, T.
    Li, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S163 - S164
  • [48] KRAS-Mutant Lung Cancers in the Era of Targeted Therapy
    Naidoo, Jarushka
    Drilon, Alexander
    LUNG CANCER AND PERSONALIZED MEDICINE: CURRENT KNOWLEDGE AND THERAPIES, 2016, 893 : 155 - 178
  • [49] Development of siRNA Payloads to Target KRAS-Mutant Cancer
    Yuan, Tina L.
    Fellmann, Christof
    Lee, Chih-Shia
    Ritchie, Cayde D.
    Thapar, Vishal
    Lee, Liam G.
    Hsu, Dennis J.
    Grace, Danielle
    Carver, Joseph O.
    Zuber, Johannes
    Luo, Ji
    McCormick, Frank
    Lowe, Scott W.
    CANCER DISCOVERY, 2014, 4 (10) : 1182 - 1197
  • [50] EMT-Associated Response and Resistance to MEK Inhibitor and Immune Checkpoint Blockade Combinations in KRAS-Mutant NSCLC
    Gaudreau, P.
    Peng, D.
    Rodriguez, B.
    Fradette, J.
    Gibson, L.
    Della Corte, C.
    Sen, T.
    Kundu, S.
    Chen, L.
    Wargo, J.
    Gibbons, D.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S449 - S450
12345